Long-term results of preoperative chemoradiation for distal rectal cancer correlation between final stage and survival.
about
Risk factors for local recurrence following neoadjuvant chemoradiotherapy for rectal cancersReview of current best practice and priorities for research in radiation oncology for elderly patients with cancer: the International Society of Geriatric Oncology (SIOG) task forceCurrent approaches and challenges for monitoring treatment response in colon and rectal cancerCombination of SELDI-TOF-MS and data mining provides early-stage response prediction for rectal tumors undergoing multimodal neoadjuvant therapy.Immunohistochemical detection of p53 expression in patients with preoperative chemoradiation for rectal cancer: association with prognosisA pilot feasibility study of TNFerade™ biologic with capecitabine and radiation therapy followed by surgical resection for the treatment of rectal cancerRecent advances in the management of carcinoma of the rectumPredicting complete response: is there a role for non-operative management of rectal cancer?Revisiting stapled and handsewn loop ileostomy closures: a large retrospective series.Predicting tumor response after preoperative chemoradiation using clinical parameters in rectal cancer.Neoadjuvant treatment response as an early response indicator for patients with rectal cancerResponse to chemoradiotherapy and lymph node involvement in locally advanced rectal cancerTreatment of locally advanced rectal cancer: controversies and questions.Accurate staging, selective preoperative therapy and optimal surgery improves outcome in rectal cancer: a review of the recent evidence.Saving the sphincter in rectal cancer: are we prepared to change practice?Surgery for Locally Advanced T4 Rectal Cancer: Strategies and Techniques.Predictors of Pathologic Complete Response in Rectal Cancer Patients Undergoing Total Mesorectal Excision After Preoperative Chemoradiation.Diffusion-weighted magnetic resonance imaging for predicting the response of rectal cancer to neoadjuvant concurrent chemoradiation.Mismatch Repair Gene Expression as a Predictor of Tumor Responses in Patients With Rectal Cancer Treated With Preoperative Chemoradiation.Is Pathologic Near-Total Regression an Appropriate Indicator of a Good Response to Preoperative Chemoradiotherapy Based on Oncologic Outcome of Disease?Influence of Preoperative Chemoradiotherapy on the Surgical Strategy According to the Clinical T Stage of Patients With Rectal Cancer.Shifting concepts in rectal cancer management: a review of contemporary primary rectal cancer treatment strategies.Critical appraisal of the 'wait and see' approach in rectal cancer for clinical complete responders after chemoradiation.Pathological complete response after neoadjuvant therapy for rectal cancer and the role of adjuvant therapy.Clinical and molecular diagnosis of pathologic complete response in rectal cancer.Optimal therapy for resectable rectal cancer.The impact of surgical diversion before neoadjuvant therapy for rectal cancer.Single nucleotide polymorphisms in the HIF-1α gene and chemoradiotherapy of locally advanced rectal cancer.Could a wait and see policy be justified in T3/4 rectal cancers after chemo-radiotherapy?Immunohistological expression of HIF-1α, GLUT-1, Bcl-2 and Ki-67 in consecutive biopsies during chemoradiotherapy in patients with rectal cancer.Fifteen different 18F-FDG PET/CT qualitative and quantitative parameters investigated as pathological response predictors of locally advanced rectal cancer treated by neoadjuvant chemoradiation therapy.miRNA expressions in rectal cancer as predictors of response to neoadjuvant chemoradiation therapy.Changing operative strategy from abdominoperineal resection to sphincter preservation in T3 low rectal cancer after downstaging by neoadjuvant chemoradiation: a preliminary report.Quantitative intravoxel incoherent motion parameters derived from whole-tumor volume for assessing pathological complete response to neoadjuvant chemotherapy in locally advanced rectal cancer.Predictive factors for survival in neoadjuvant radiochemotherapy for advanced rectal cancer.Difference in Tumor Area as a Predictor of a Pathological Complete Response for Patients With Locally Advanced Rectal Cancer.Exercise during and after neoadjuvant rectal cancer treatment (the EXERT trial): study protocol for a randomized controlled trial.Assessment of pathological complete response to preoperative chemoradiotherapy by means of multiple mathematical models of diffusion-weighted MRI in locally advanced rectal cancer: A prospective single-center study.Clinicopathological characteristics predict lymph node metastases in ypT0-2 rectal cancer after chemoradiotherapy.Chromosomal instability portends superior response of rectal adenocarcinoma to chemoradiation therapy.
P2860
Q26853016-D4D58D89-E9D5-4749-AB21-655C7D82160AQ27009163-95A821CF-D11A-42B3-8888-FF26E921BA37Q27010257-C90B9473-E3DA-49BC-AE84-0F1153A68933Q31095551-6EBF3B49-1CF5-4E33-A18C-B0BF98B74970Q34774255-0601F1EC-D16E-4857-BB64-7ACD68A57C8FQ34803980-9A9D910B-1ECE-457C-8B74-CC975368EEA1Q35026254-88F4FCA9-5C9E-48B0-BC2C-EB67FA453B4FQ35029046-19C0F957-3BD3-4FB6-9799-E567614E3D07Q35473377-F2A1C1CD-80FF-4D8A-91E2-064BC817307AQ35638806-F0660CB1-266F-4D0C-8DA4-1090E7E21277Q36058487-974690BB-8561-4E7B-BA62-95A2F83587B7Q36091170-B24BE38B-FB5B-4B1F-A5B0-91F834E4A31FQ36351882-BCB376C4-9F0A-4F35-8DF5-DF823F5597C7Q36791079-ECA68AAA-5BA6-4899-B34F-9D5334BCE615Q36791084-BF5B92B0-53FF-4FFF-8D0C-7D1AC94A5777Q36940434-DC756D02-FEC1-4925-8933-815D0130FE44Q37016683-1D9A90A5-673E-4B02-A3C5-C39922AF1B0AQ37142235-D83394AE-9F9E-4F60-AD2C-ADC15437C35BQ37205031-C0A3B977-578C-4BC7-A04D-AE80343F725EQ37328335-4C56A9D7-AD61-4F27-A406-10AB4A1694CAQ37624231-6835ECA2-62F1-491B-9224-70659C6C0792Q38001344-257F0684-AFBD-47BF-B3A4-17B347B15164Q38005955-08341008-4B7E-4AF8-AEDE-C1ECA51CBE9FQ38079162-E8167B4C-FAFE-4E1F-9CAF-C99083374670Q38594617-D69E6295-22A8-45C3-9851-A6D0EAB87E2DQ38664897-2405C979-CD50-4076-B6C7-4D1E3472DD57Q40939163-7D6FF56B-955E-485C-96A4-6421792ECF5BQ41116476-D2489165-B5A9-4081-AABC-454C22A90CBAQ43431563-332910AF-6039-4D30-85F0-51963EED92A9Q43569725-C5B3D786-9956-424A-BE12-C7EAB54E51CFQ43822307-9899F323-64D0-4CB3-A06E-D5F42D849B43Q46294728-44A50EC8-3904-4495-B546-256FFE393CB1Q46522532-06EA886B-62AC-41D6-848F-C3E6C6286436Q47243646-57C6538F-9E62-4910-A752-58AB9E42A79CQ48315037-39BD9B23-1FF8-4DE9-83B0-4AE3B430844EQ49728422-18400205-2D1E-4D34-BA9C-FE718A7C3740Q49748146-F26B607D-E7A6-4280-B9F3-0A75FB54DFA8Q50532758-7869D0BF-13D9-4039-B5B0-90ABABF27C01Q50631955-580DF6AE-8229-4F1E-82E6-9F94EF35CCA6Q51104404-8582EEC8-8DF8-4D07-A44E-C37C7BD4E2DA
P2860
Long-term results of preoperative chemoradiation for distal rectal cancer correlation between final stage and survival.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Long-term results of preoperat ...... ween final stage and survival.
@en
Long-term results of preoperat ...... ween final stage and survival.
@nl
type
label
Long-term results of preoperat ...... ween final stage and survival.
@en
Long-term results of preoperat ...... ween final stage and survival.
@nl
prefLabel
Long-term results of preoperat ...... ween final stage and survival.
@en
Long-term results of preoperat ...... ween final stage and survival.
@nl
P2093
P1476
Long-term results of preoperat ...... tween final stage and survival
@en
P2093
Afonso Henrique Silva E Sousa
Angelita Habr-Gama
Desidério Roberto Kiss
Fábio Guilherme Campos
Joaquim Gama-Rodrigues
Rodrigo Oliva Perez
Wladimir Nadalin
P2888
P304
90-9; discussion 99-101
P356
10.1016/J.GASSUR.2004.10.010
P577
2005-01-01T00:00:00Z
P6179
1001467233